65 results match your criteria: "Hospitales Vithas[Affiliation]"
Brain Sci
January 2025
RISE-Health, Center for Translational Health and Medical Biotechnology Research (TBIO), ESS, Polytechnic of Porto, R. Dr. António Bernardino de Almeida, 400, 4200-072 Porto, Portugal.
Background: Clinicians are challenged by the ambiguity and uncertainty in assessing level of consciousness in individuals with disorder of consciousness (DoC). There are numerous challenges to valid and reliable neurobehavioral assessment and classification of DoC due to multiple environmental and patient-related biases including behavioral fluctuation and confounding or co-occurring medical conditions. Addressing these biases could impact accuracy of assessment and is an important aspect of the DoC assessment process.
View Article and Find Full Text PDFNeurologia (Engl Ed)
January 2025
Red Menni de Daño Cerebral, Bilbao, Spain.
Introduction: Clinical practice guidelines in neurorehabilitation for adults with disorders of consciousness by the Spanish Neurorehabilitation Society. This document is based on a review of international clinical practice guidelines published between 2015 and 2022.
Method: A total of 7 articles, corresponding to 5 clinical practice guidelines published between 2015 and 2022, were selected by the group of authors from a pool of 48 bibliographic references extracted from various databases in accordance with predefined search criteria.
Clin Neurophysiol
December 2024
Institute for Human-Centered Technology Research, Universitat Politècnica de València, Camino de Vera s/n, Valencia 46011, Spain. Electronic address:
Objective: To investigate the differences in the brain responses of healthy controls (HC) and patients with disorders of consciousness (DOC) to familiar and non-familiar audiovisual stimuli and their consistency with the clinical progress.
Methods: EEG responses of 19 HC and 19 patients with DOC were recorded while watching emotionally-valenced familiar and non-familiar videos. Differential entropy of the EEG recordings was used to train machine learning models aimed to distinguish brain responses to stimuli type.
Rehabilitacion (Madr)
November 2024
Universidad Autónoma, Barcelona, España; Hospital de Sant Pau, Barcelona, España.
Introduction And Objective: Certain medical practices, both diagnostic and therapeutic, that have not been proven to be effective and do not add value to healthcare, are not uncommon. The aim of this document is to provide a list of «Not to do» recommendations in the medical specialty of Physical Medicine and Rehabilitation.
Material And Method: For the development of this project, which is coordinated by the Vocalía de Sociedades Filiales, Sociedades Autonómicas y Grupos de Trabajo de la Sociedad Española de Rehabilitación (SERMEF), specific recommendations are requested from Grupos de Trabajo and Sociedades Filiales of each specific field of Physical Medicine and Rehabilitation, as experts in the corresponding intervention areas.
Int J Mol Sci
October 2024
Faculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Madrid, Spain.
The isolation of circulating tumoral DNA (ctDNA) present in the bloodstream brings about the opportunity to detect genomic aberrations from the tumor of origin. However, the low amounts of ctDNA present in liquid biopsy samples makes the development of highly sensitive techniques necessary to detect targetable mutations for the diagnosis, prognosis, and monitoring of cancer patients. Here, we employ standard genomic DNA (gDNA) and eight liquid biopsy samples from different cancer patients to examine the newly described CRISPR-Cas13a-based technology in the detection of the BRAF p.
View Article and Find Full Text PDFJ Clin Med
September 2024
Santa Lucia Foundation, Scientific Institute for Research and Health Care, 00179 Rome, RM, Italy.
Persons with disorders of consciousness (DoCs) may perceive pain without being able to communicate their discomfort. The Nociception Coma Scale (NCS) and its revised form (NCS-R) have been proposed to assess nociception in persons with DoCs. The main aim of this international multicenter study was to confirm (or not) our preliminary results and compare the NCS-R scores of standard stimulus (NCS-R-SS) to scores of personalized painful stimuli (NCS-R-PS).
View Article and Find Full Text PDFMol Oncol
August 2024
Instituto de Biomedicina y Departamento de Biología Molecular, Universidad de León, Spain.
Glioblastoma (GB) is the most common and fatal type of primary malignant brain tumor for which effective therapeutics are still lacking. GB stem cells, with tumor-initiating and self-renewal capacity, are mostly responsible for GB malignancy, representing a crucial target for therapies. The TP73 gene, which is highly expressed in GB, gives rise to the TAp73 isoform, a pleiotropic protein that regulates neural stem cell biology; however, its role in cancer has been highly controversial.
View Article and Find Full Text PDFInt J Mol Sci
June 2024
Instituto de Investigación Biomédica de Málaga y Plataforma de Nanomedicina-IBIMA Plataforma BIONAND, 29590 Málaga, Spain.
A central role for neuroinflammation in epileptogenesis has recently been suggested by several investigations. This systematic review explores the role of inflammatory mediators in epileptogenesis, its association with seizure severity, and its correlation with drug-resistant epilepsy (DRE). The study analysed articles published in JCR journals from 2019 to 2024.
View Article and Find Full Text PDFPharmaceuticals (Basel)
April 2024
Laboratorio de Biología Tumoral, Instituto de Bioquímica y Microbiología, Facultad de Ciencias, Universidad Austral de Chile, Valdivia 5090000, Chile.
Glioblastoma (GB) is the most aggressive and common primary malignant tumor of the brain and central nervous system. Without treatment, the average patient survival time is about six months, which can be extended to fifteen months with multimodal therapies. The chemoresistance observed in GB is, in part, attributed to the presence of a subpopulation of glioblastoma-like stem cells (GSCs) that are characterized by heightened tumorigenic capacity and chemoresistance.
View Article and Find Full Text PDFPediatr Neurol
June 2024
IRENEA, Instituto de Rehabilitación Neurológica, Fundación Hospitales Vithas, València, Spain.
NeuroRehabilitation
January 2024
IRENEA-Instituto de Rehabilitación Neurológica, Fundación Hospitales Vithas, Valencia, Spain.
Background: A few studies specifically addressed medical comorbidities (MCs) in patients with severe acquired traumatic or non-traumatic brain injury and prolonged disorders of consciousness (pDoC; i.e., patients in vegetative state/unresponsive wakefulness syndrome, VS/UWS, or in minimally conscious state, MCS).
View Article and Find Full Text PDFFront Psychol
August 2023
Neurorehabilitation and Brain Research Group, Instituto de Investigación e Innovación en Bioingeniería, Universitat Politècnica de València, Valencia, Spain.
Purpose: A systematic review was conducted to examine the state of the literature regarding using ecologically valid virtual environments and related technologies to assess and rehabilitate people with Acquired Brain Injury (ABI).
Materials And Methods: A literature search was performed following the PRISMA guidelines using PubMed, Web of Science, ACM and IEEE databases. The focus was on assessment and intervention studies using ecologically valid virtual environments (VE).
Eur J Neurol
October 2023
Coma Science Group, GIGA-Consciousness, Centre du Cerveau2, University and University Hospital of Liège, Liège, Belgium.
Background And Purpose: Transcranial direct current stimulation (tDCS) has been shown to improve signs of consciousness in a subset of patients with disorders of consciousness (DoC). However, no multicentre study confirmed its efficacy when applied during rehabilitation. In this randomized controlled double-blind study, the effects of tDCS whilst patients were in rehabilitation were tested at the group level and according to their diagnosis and aetiology to better target DoC patients who might repond to tDCS.
View Article and Find Full Text PDFCrit Rev Oncol Hematol
September 2023
Faculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Madrid, Spain. Electronic address:
Colorectal cancer (CRC) is the third most common malignant tumor and one of the deadliest cancers. At molecular level, CRC is a heterogeneous disease that could be divided in four Consensus Molecular Subtypes. Given the differences in the disease due to its anatomical location (proximal and distal colon), another classification should be considered.
View Article and Find Full Text PDFNeurology
August 2023
From the School of Biomedical Engineering & Imaging Sciences (E.M., L.S.S.C.), Faculty of Life Science & Medicine, King's College London, United Kingdom; Department of Physical Medicine and Rehabilitation (M.-M.B.), Hôpital du Sacré-Coeur de Montréal, Quebec, Canada; IRCCS Fondazione Don Gnocchi (A.E.), Florence, Sant'Angelo dei Lombardi, Italy; NEURORHB-Neuro Rehab Human Brain (C.C.F.), Fundación Hospitales Vithas, Valencia, Spain; IRCCS Santa Lucia Foundation (R.F.), Rome, Italy; Clinical and Research Institute of Emergency Pediatric Surgery and Trauma (CRIEPST) (E.F.), Moscow, Russia; Coma Science Group (O.G.), GIGA Consciousness & Centre du Cerveau2, University and University Hospital of Liège, Belgium; Department of Neuropsychology (R.A.H.), Children's Healthcare of Atlanta, GA; Neurophysiology Unit (P.L.), Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; Centro de Rehabilitación Infantil CRI CETNA (G.I.L.), Fleni, Buenos Aires, Argentina; Boyer College of Music and Dance (W.L.M.), Temple University, Philadelphia, PA; Division of Clinical Neuropsychology (V.V.), Subang Jaya Medical Center, Selangor; Division of Clinical Neuropsychology (V.V.), Thompson Hospital Kota Damanasara, Selangor, Malaysia; Department of Physical Medicine and Rehabilitation (P.W.), University of Colorado, Children's Hospital Colorado, Aurora; Division of Neurosurgery (T.Y.), Rehabilitation Center for Traumatic Apallics Chiba, National Agency for Automotive Safety and Victims' Aid, Japan; and Department of Neuropsychology (B.S.S.), Kennedy Krieger Institute; Department of Psychiatry and Behavioral Sciences (B.S.S.), Johns Hopkins University, School of Medicine, Baltimore, MD.
Background And Objectives: Comprehensive guidelines for the diagnosis, prognosis, and treatment of disorders of consciousness (DoC) in pediatric patients have not yet been released. We aimed to summarize available evidence for DoC with >14 days duration to support the future development of guidelines for children, adolescents and young adults aged 6 months-18 years.
Methods: This scoping review was reported based on Preferred Reporting Items for Systematic reviews and Meta-Analyses-extension for Scoping Reviews guidelines.
Biomolecules
April 2023
International School for Advanced Studies (ISAS-SISSA), 34136 Trieste, Italy.
Nanomaterials design, synthesis, and characterization are ever-expanding approaches toward developing biodevices or neural interfaces to treat neurological diseases. The ability of nanomaterials features to tune neuronal networks' morphology or functionality is still under study. In this work, we unveil how interfacing mammalian brain cultured neurons and iron oxide nanowires' (NWs) orientation affect neuronal and glial densities and network activity.
View Article and Find Full Text PDFNeurologia (Engl Ed)
April 2024
NEURORHB Servicio de Neurorrehabilitación de Hospitales Vithas, Fundación Hospitales Vithas, Valencia, Spain.
Introduction: We present the Spanish Society of Neurorehabilitation's guidelines for adult acquired brain injury (ABI) rehabilitation. These recommendations are based on a review of international clinical practice guidelines published between 2013 and 2020.
Development: We establish recommendations based on the levels of evidence of the studies reviewed and expert consensus on population characteristics and the specific aspects of the intervention or procedure under research.
Rehabilitacion (Madr)
April 2023
Servicio de Rehabilitación, Hospital Universitario Marqués de Valdecilla, Santander, España.
Brain Sci
December 2022
IRCCS Fondazione Don Carlo Gnocchi ONLUS, 50143 Firenze, Italy.
Prognosis of prolonged Disorders of Consciousness (pDoC) is influenced by patients' clinical diagnosis and Coma Recovery Scale-Revised (CRS-R) total score. We compared the prognostic accuracy of a novel Consciousness Domain Index (CDI) with that of clinical diagnosis and CRS-R total score, for recovery of full consciousness at 6-, 12-, and 24-months post-injury. The CDI was obtained by a combination of the six CRS-R subscales via an unsupervised machine learning technique.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
December 2022
Neurovascular Research Laboratory, Vall d'Hebron Institute of Research (VHIR)-Universitat Autónoma de Barcelona, Barcelona, Spain; Neurovascular Research Laboratory, Institute of Biomedicine of Seville-IBIS, Sevilla, Spain. Electronic address:
Background: Atrial fibrillation (AF) has been associated with an increased risk of silent brain infarcts (SBI) and cognitive impairment, even in patients with low embolic risk. We aimed to test the association between 11 blood-biomarkers representing different AF-related pathways, and SBI, white matter hyperintensities (WMH), and cognitive decline in patients with AF and low embolic risk.
Methods: The present study followed a cross-sectional design.
Introduction: Type 1 narcolepsy is a disabling disease that requires continuous treatment, which is not always effective. Pitolisant is a new drug with a different mechanism of action that offers a new treatment option. The objective of the study was to analyse the effectiveness and safety of pitolisant in patients with type 1 narcolepsy that did not respond to or tolerate previous standard treatments.
View Article and Find Full Text PDFFront Oncol
August 2022
Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
Gliomas are the most common brain tumors, which present poor prognosis, due, in part, to tumor cell migration and infiltration into distant brain areas. However, the underlying mechanisms causing such effects are unknown. Hedgehog (HH)-Gli axis is one of the signaling pathways involved, with a high number of molecular mediators.
View Article and Find Full Text PDFFront Oncol
August 2022
Tumor biology laboratory, Institute of Biochemistry and Microbiology, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile.
Glioblastoma (GBM) is the most common and deadly malignant brain tumor, with a median survival of 15 to 17 months for a patient. GBM contains a cellular subpopulation known as GBM stem-like cells (GSCs) that persist in hypoxic niches and are capable of infiltrating into healthy brain tissue. For this reason, GSCs are considered one of the main culprits for GBM recurrence.
View Article and Find Full Text PDFFront Hum Neurosci
August 2022
IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.